Nestle to Buy Pfizer Nutrition for $11.9

New Post Public Reply Private Reply Replies (0) Message Board
Stock Buff

Nestle to Buy Pfizer Nutrition for $11.9 Billion

Published: Monday, 23 Apr 2012 | 5:02 AM ET
By: Reuters

Swiss food group Nestle is to buy U.S. drugmaker Pfizer 's infant nutrition business for $11.85 billion, beating out French rival Danone in the battle for dominance of baby food in fast-growing emerging markets.

 

AP

Nestle [ NESM-DE   46.105     -1.16   ( -2.45% )   ] , the world's biggest food company, was already seen as likely to win the battle due to its deep pockets after it sold its stake in eyecare group Alcon to Novartis [ NVS   56.38     0.91   ( +1.64% )   ] , and has refrained from announcing a new share buyback program.

The fight for the  Pfizer [ PFE   22.56     0.225   ( +1.01% )   ] unit, which makes 85 percent of its sales in emerging markets, had intensified last week, with the price escalating sharply from bids around $10 billion after Danone [   Loading...       ()   ] was reported to have raised its offer on Friday.

The acquisition, which is subject to regulatory approval, is expected to close in mid 2013 and will help Nestle extend its lead in the infant formula market.

"The price tag is high, however Nestle is securing a high growth/margin business with high exposure in the emerging markets. China will become the number 3 market for Nestle overall," said Vontobel analyst Jean-Philippe Bertschy.

Nestle said the deal would be add to earning per share from the first year, and would allow cost synergies of $160 million. Bertschy estimated the deal would add about 0.5 percent to earnings per share in the first year and 1.5 percent in the following years.

Nestle [ NESM-DE   46.105     -1.16   ( -2.45% )   ] shares, which hit an all-time high of 57.50 francs ahead of solid first-quarter results last week, fell 3.06 percent to 55.35 francs at 8:00 a.m. London time as they traded ex-dividend, compared with a 1.11 percent weaker European food and beverage [ .SX3P   412.28     -4.32   ( -1.04% )   ] index.

"Although the growth profile, attractive margins and emerging market exposure makes this a compelling asset, we believe that the multiples being some way ahead of market expectations may dampen near term enthusiasm for the deal," said Citi analyst Robert Dickinson.

The $11.85 billion value of the deal was above the $10 billion which had been expected, and ahead of previous Nestle deals in the sector when it paid 15.7 times for Gerber and 17.6 times for Novartis Nutrition, according to Citi.

Chinese Market Key

The Pfizer unit is a high-growth business built on its top SMA Gold brand. Some 60 percent of sales are in Asia, 30 percent in Europe, largely Britain, and 10 percent in Latin America.

It ranks number five globally in the infant milk formula market — the world's fastest-growing packaged food category — after Nestle, Mead Johnson [ MJN.F   63.145     -0.949   ( -1.48% )   ] , Danone and Abbott Laboratories [ ABT.F   45.098     0.138   ( +0.31% )   ] , with a quarter of sale in the buoyant Chinese market.

The $6 billion Chinese market is key as it is set to double to $12 billion by 2016 having grown at more than 20 percent a year over the last five years to feed 16 million new births a year. Mead leads the Chinese market with a 16 percent share followed by Danone with 14 percent, Pfizer is fifth with an 8 percent share, while Nestle has just 4 percent.

Nestle's roots go back to the 1860s development by Henri Nestle, a pharmacist, of the first infant formula for babies whose mothers who could not breast feed.

"Pfizer Nutrition is an excellent strategic fit and this acquisition underlines our commitment to be the world's leading nutrition, health and wellness company," Chief Executive Paul Bulcke said on Monday.

The Vevey-based firm expects the acquisition will generate sales of $2.4 billion this year and boost margins, thanks to its large exposure to fast-growing emerging markets.

Nestle, which expects emerging markets to account for half of sales by 2020 from 41 percent last year, has been an active player in recent emerging markets merger activity, taking stakes in two Chinese food companies.

"The deal makes strategic sense, it really was Nestle's deal to lose as it very much wanted to add to its Asian business and boost growth and margins," said Kepler analyst Jon Cox. "The price being paid seems quite high, by my calculations it's at 22 times core earnings, almost as high as Danone's infamous 2007 acquisition of Numico ."

Danone paid 12.3 billion euros in 2007 for Dutch food group Numico, at the time Europe's largest baby food producer, paying a similar multiple, a price many analysts said was too high.

Pfizer put its infant nutrition and animal health businesses up for sale last July as it looks to focus on its core pharmaceuticals business.

http://www.cnbc.com/id/47138745

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bill Targets 15% Federal Goal for Women-Owned Firms

Updated Category News Views 28

Federal procurement has a stubborn habit of sounding abstract until you remember that contracts can decide whether a small company hires, invests, or simply keeps the lights on. Senator Adam Schiff introduced the Women's Economic Fairness and Small Business Contracting Act on November 19, 2026, proposing to raise the federal goal for Women-Owned Small Businesses from 5%...

Continue Reading
Vizsla's Panuco Delay Puts Security Ahead of Speed

Updated Category News Views 110

A mine schedule can absorb a calendar slip; the people around a mine cannot be treated like a line item. Vizsla Silver's update on Panuco is therefore not the usual development-company chest thumping. It is a sober admission that security, permitting and site readiness have pushed first silver to the second half of 2028, one year later than the prior H2 2027 target....

Continue Reading
Lowe's Dec. 9 Conference Puts Strategy on the Clock

Updated Category News Views 0

A Calendar Entry With Real Weight December 9 is not earnings day, but it is the sort of date shareholders ought to circle anyway. Lowe's plans to hold its 2026 Analyst and Investor Conference at 8 a.m. Eastern time in New York City, with a live webcast available for those not sitting in the room. For owners of NYSE:LOW, these gatherings can be more useful than the usual...

Continue Reading
Corner Bakery Bets on Holiday Catering Convenience

Updated Category News Views 51

A $50 carrot on a $350 catering tab tells you exactly where Corner Bakery sees the holiday battlefield: not in one lonely cookie sale, but in the larger group order that can make a restaurant’s day. The chain is pushing holiday catering through November and December, pairing that discount with bakery trays, meals for groups and a promise to handle delivery setup. It is...

Continue Reading
A Quanzhou Table Offers China Beyond the Headlines

Updated Category News Views 150

Steam rising from a Quanzhou table can carry more weight than another polished speech about cultural exchange. That is the sensible instinct behind Home Banquets with Master Chefs, the CCTV-4 series using regional meals to explore geography, customs and memory. It is not trying to explain China through a pile of statistics or a museum-label summary. It starts where people...

Continue Reading
Receipts Turns Vegas Party Shirts Into AR Keepsakes

Updated Category News Views 118

A shirt that coughs up a Vegas weekend when scanned is either a smart little keepsake trick or a privacy headache wearing sequins. Receipts™, introduced by Las Vegas-based Naked City Couture and the AR Trading Card Company, is betting it can be the former. The concept is simple enough: friends wear the apparel, capture photos and videos during a trip, upload those...

Continue Reading
PARRIS Partners Earn 2026 Plaintiff Lawyer Recognition

Updated Category News Views 95

A $58.4 million jury number can make a courtroom sound like a slot machine, until the final settlement lands at $21 million. That gap is the part people ought to stare at before getting carried away by another plaintiff-lawyer honor roll. The Daily Journal has named PARRIS Law Firm partners Alexander R. Wheeler and Khail A. Parris to its 2026 Top Plaintiff Lawyers special...

Continue Reading
Yiwu Squishies Turn Viral Demand Into Factory Backlogs Worldwide

Updated Category News Views 55

A pizza-shaped stress toy booking more than one million units is the sort of detail that makes a jaded market watcher sit up before rolling his eyes at the word “viral.” Yiwu’s squishy-toy surge appears to have moved beyond a few social-media impulses and into actual factory scheduling, repeat purchase orders and supermarket procurement. That is meaningful. It is...

Continue Reading
Cirrus CEO Takes SIA Chair as Chip Policy Heats Up

Updated Category News Views 17

A trade-group gavel rarely moves a stock by itself, but this one lands in a noisy part of the chip cycle. On November 19, 2026, the Semiconductor Industry Association elected Cirrus Logic President and CEO John Forsyth as chair of its board. That is not a revenue announcement, not a factory groundbreaking, and certainly not a reason to start flinging confetti at...

Continue Reading
ROHM's GaN PFC Chip Targets the Power-Supply Squeeze

Updated Category News Views 118

Power supplies are where a lot of sleek electronics quietly lose the plot, and ROHM is taking a proper swing at that problem. Its new BM85060FV is a totem-pole power factor correction controller built for gallium nitride, or GaN, high-frequency switching in AC-DC power supplies. The headline is not subtle: ROHM says a 300 to 500 W system using the chip can reach 99%...

Continue Reading

Top 5 Most Recently Viewed Articles

Addgene Launches Innovative Antibody Characterization Platform

Updated Category News Views 109

Addgene Launches Innovative Antibody Characterization Platform Addgene, a visionary organization dedicated to enhancing scientific research, recently introduced a groundbreaking antibody characterization platform that draws from its extensive antibody catalog. This initiative aims to significantly advance the field of biomedical research by ensuring that antibodies are...

Continue Reading
Nishant Saxena Joins Jeune Aesthetics as CFO to Drive Growth

Updated Category News Views 294

Jeune Aesthetics Welcomes New Chief Financial Officer Jeune Aesthetics has taken a significant step forward by appointing Nishant Saxena as its Chief Financial Officer (CFO). This decision comes at a crucial time as the company prepares to advance its growth strategies and innovate in the field of medical aesthetics designed to combat aging skin. Understanding the...

Continue Reading
Organ Preservation Solutions Market to Reach $512.62 Million by 2031

Updated Category News Views 144

Growth of the Organ Preservation Solutions Market The organ preservation solutions market is experiencing significant growth as the global demand for organ transplantation rises. According to a comprehensive report from The Insight Partners, it is projected that this market will reach a remarkable $512.62 million by 2031 with a compound annual growth rate (CAGR) of 8.1%....

Continue Reading
Alpine Income Property Trust Secures $14.1 Million Mortgage Loan

Updated Category News Views 133

Alpine Income Property Trust Makes Strategic Mortgage Investment WINTER PARK, Fla. – Alpine Income Property Trust, Inc. (NYSE: PINE), a well-known real estate investment trust, has recently announced a significant investment by originating a first mortgage loan. The loan investment, amounting to $14.1 million, is secured by a luxury residential development featuring...

Continue Reading
Zenity Introduces New Framework for Securing GenAI Systems

Updated Category News Views 127

Zenity Introduces GenAI Attacks Matrix for Enhanced Security Zenity, a leader in the security domain for enterprise copilots and low-code development, has launched its innovative security framework known as the GenAI Attacks Matrix. This open-source initiative is inspired by the renowned MITRE ATLAS and developed with contributions from top security researchers worldwide,...

Continue Reading